|
|
Gene Symbol |
GDF9 |
|
Aliases |
POF14 |
|
Entrez Gene ID |
|
|
Gene Name |
Growth differentiation factor 9 |
|
Chromosomal Location |
5q31.1 |
|
HGNC ID |
|
|
Summary |
This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate each subunit of the disulfide-linked homodimer. This protein regulates ovarian function. Reduced expression of this gene may be associated with polycystic ovary syndrome and mutations in this gene may be more common in mothers of dizygotic twins. [provided by RefSeq, Jul 2016]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
Protein Information |
|
Protein Name |
Growth/differentiation factor 9 |
|
Function |
Required for ovarian folliculogenesis. Promotes primordial follicle development. Stimulates granulosa cell proliferation. Promotes cell transition from G0/G1 to S and G2/M phases, through an increase of CCND1 and CCNE1 expression, and RB1 phosphorylation. It regulates STAR expression and cAMP-dependent progesterone release in granulosa and thecal cells. Attenuates the suppressive effects of activin A on STAR expression and progesterone production by increasing the expression of inhibin B. It suppresses FST and FSTL3 production in granulosa-lutein cells. |
|
|
|
|
|
UniProt |
|
|
Pfam |
Pfam Accession |
Pfam ID |
PF00019 |
TGF_beta |
|
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000269216 |
Q92908 |
Q92908 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Endocrine System Diseases |
PCOS |
|
Neoplasms |
Ovarian Cancer |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
|
|
|
NIH criteria |
Related
|
24 (5 PCOS, 7 PCO, 12 controls) |
The expression of GDF-9 mRNA is delayed and reduced in PCOS and PCO oocytes during their growth and differentiation phase. Because oocyte-derived GDF-9 is crucial for normal folliculogenesis and female fertility, the study suggests that a dysregulation of oocyte GDF-9 expression may contribute to aberrant folliculogenesis in PCOS and PCO women |
|
BMP15, AMH, AMHR2 |
|
|
NIH criteria |
Related
|
335 PCOS cases, 198 controls |
Certain GDF9 variants were associated with hirsutism scores and parity in PCOS patients |
|
BMP15 |
|
|
|
Direct
|
28 women with PCOS, 26 controls |
The expression of these proteins is reduced and delayed in the early follicular stage in PCOS ovarian tissues, and these differences in expression may be associated with aberrant follicular development in patients with PCOS |
|
|
|
|